BioSpace News Archive

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSXV:TBP)(OTCQB:TBPMF), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, today announces the departure of one of its members of the Board of Directors (the “Board).

ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally-invasive medical devices to treat obesity and metabolic diseases, today announced a partnership with inHealth Lifestyle Therapeutics (formerly inHealth Medical Services), a Lifestyle Therapeutics company, to launch the ReShapeCare™ virtual health coaching program this month.

An essential part of scientific training is learning to communicate new findings in manuscripts and theses. But access to scientific writing training, mentoring, and support varies widely, and many early career scientists report a need for more intensive help in developing their skills.

Amgen (NASDAQ: AMGN) today announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum (ENL), an inflammatory cutaneous and systemic complication of leprosy.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it plans to provide in the first half of July 2020 an overview of preliminary results for the second quarter and first half of 2020, along with perspectives on anticipated business trends for the third quarter of 2020.

OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced the closing of its underwritten public offering of 1,600,000 shares of its common stock at a price to the public of $47.00 per share.

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that it has commenced a proposed underwritten public offering of 1,500,000 shares of its common stock.

ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the publication of the results of its multi-center clinical study of the ReStore Exo-Suit for rehabilitation of individuals with lower limb disability due to stroke

Abivax SA (Euronext Paris: FR0012333284 - ABVX), a late stage clinical biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today provides an update on its most recent clinical and financial achievements and developments and announces the positive results of the annual ordinary and extraordinary general meeting held on June 19, 2020.

Medical gowns are one of the most important pieces of personal protective equipment in the fight against COVID-19. In order to protect themselves from the coronavirus and other pathogens, frontline healthcare workers need medical gowns along with masks, plastic face shields, booties and other protective equipment